Home Mission Standards Leadership Publications Investor Diligence Finance Leadership Vision About Chair's Letter Contact AIMed '25 ↗

Clinical Outcomes

Clinical Validation of AI in Healthcare

Last reviewed: September 22, 2026

Clinical AI evaluation is a fast-moving field. Confirm current requirements with the primary sources linked below.

Boundary

TTIC’s role

TTIC Scope: Boundary

TTIC addresses clinical validation only to distinguish it from technical assurance and TIPPSS. Clinical validation remains the responsibility of appropriately qualified authorities.

TTIC does not perform, certify, approve, or substitute for clinical validation.

TTIC provides definitions and governance context that help practitioners distinguish clinical validation from technical verification, technical validation, regulatory review, governance review, and institutional deployment authorization.

Clinical validation and evaluation remain the responsibility of appropriately qualified clinical, research, regulatory, and institutional authorities.

Neither a TTIC Certification Pathway tier nor TIPPSS governance screening is a determination of clinical validity. Tiers reflect the category of clinical data contact a technology has.

Definition

What is clinical validation?

AI can be technically sound without having adequate evidence for a particular clinical use. Clinical AI evaluation must account for the intended use, patient population, clinical setting, workflow, human-AI interaction, safety, generalizability, and outcomes. The evidence needed also changes with the type and risk of the technology.

The terminology remains unsettled across engineering, clinical research, regulation, and healthcare operations. TTIC’s role is to clarify those boundaries, not collapse them.

Clinical validation evaluates whether sufficient clinical evidence supports an AI-enabled capability for a specified clinical purpose, population, setting, workflow, and context of use. The appropriate evaluation method depends on the technology, intended use, risk, available prior evidence, and applicable scientific, institutional, and regulatory requirements.

Question	Primary domain
Did we build or configure the system correctly?	Technical verification
Does the system perform according to defined technical requirements?	Technical validation
Is there adequate clinical evidence for the relevant clinical purpose, population, setting, and context?	Clinical validation / clinical evaluation
Should this institution permit this use under these conditions?	Institutional governance and accountable clinical authority
Is continued use remaining within acceptable clinical, technical, and operational parameters?	Lifecycle monitoring and reassessment

These domains interact, but none automatically substitutes for another.

Strategy

Build your basic clinical validation strategy

01What exactly will it be used for?

Write down the intended use, patient population, clinical setting, workflow, and who acts on the output. Every later answer depends on this.

02Is it regulated?

Determine whether it is a medical device in your jurisdiction and its regulatory status. Regulatory status is one input; it does not establish validity in your setting. FDA Good Machine Learning Practice · FDA AI-Enabled Medical Devices

03What evidence exists, and at what stage?

Prediction model performance: TRIPOD+AI. Early live clinical evaluation: DECIDE-AI. Clinical trials: SPIRIT-AI and CONSORT-AI.

04Does that evidence apply to you?

Compare population, setting, and workflow to yours, and name the gaps you would need to evaluate locally.

05Is technical assurance established separately?

Technical verification and validation answer a different question; neither substitutes for the other. See Verification, Validation & Evidence for AI.

06Who in your organization decides, and under what conditions?

Name the accountable authority, the conditions of use, and the limitations.

07What will you monitor, and what triggers reassessment?

Your answers are your organization’s strategy and determination, not TTIC’s.

Authority Map

Who decides?

Identify which question is being asked, who has authority to answer it, and what TTIC does at the boundary.

Question	Typical accountable authority	TTIC role
Does the technology meet defined technical requirements?	Engineering, security, quality, testing, independent technical-assurance functions as applicable	Define/connect governance concepts and relevant standards; do not perform the organization’s testing
Is there adequate evidence for the stated clinical use?	Qualified clinical investigators, research organizations, healthcare institutions, scientific authorities	Define the distinction and route practitioners to appropriate authorities/resources
Does a regulated product meet applicable regulatory requirements?	Applicable regulator and regulated entity	Point to applicable regulatory authority; do not provide regulatory approval
Should this healthcare organization permit this use?	Accountable institutional clinical/governance leadership under the organization’s authority structure	Clarify governance/accountability concepts; do not make the institutional decision
What conditions, limitations, and monitoring obligations apply?	Accountable institution, informed by clinical, technical, regulatory, risk, and operational authorities	Provide governance context and lifecycle concepts
Has evidence or performance changed enough to require reassessment?	Accountable institution and relevant clinical, technical, regulatory, or research authorities	Define lifecycle-governance concepts and routes to authority

Clinicians

Clinical evidence and professional accountability remain clinical responsibilities. Technical assurance does not substitute for clinical evidence.

CIO / CTO / Engineering

Technical performance is necessary but does not establish clinical utility or institutional authorization.

CISO / Security

Security validation addresses a different risk domain from clinical validation. Both may be material to deployment.

Quality / Safety

Clinical safety, technical reliability, workflow effects, and monitoring should be connected without treating them as interchangeable.

Legal / Compliance / Regulatory

Regulatory status is one input to institutional governance and should not be described as universal clinical validation.

Executive / Board

The governance question is not simply whether the AI is validated. It is what has been established, for which use and population, by whom, under what authority, with what limitations, and who remains accountable.

Resources

Authoritative resources

Regulatory / lifecycle

FDA / IMDRF Good Machine Learning Practice
Guiding principles for safe, effective, high-quality AI/ML-enabled medical devices across the total product lifecycle.
FDA: AI-Enabled Medical Devices
FDA’s Digital Health Center of Excellence resources consolidating AI/ML device guidance and policy materials.

Early live clinical evaluation

DECIDE-AI
A stage-specific reporting guideline for early, small-scale, live clinical evaluation of AI-based decision-support systems. A reporting guideline, not by itself evidence of methodological quality.

Clinical trials and reporting

SPIRIT-AI
AI-specific extension to clinical-trial protocol guidance, making AI interventions, intended use, inputs/outputs, and human-AI interaction more explicit at the protocol stage.
CONSORT-AI
AI-specific extension to clinical-trial reporting guidance, for the same purpose at the results-reporting stage.
TRIPOD+AI (BMJ, 2024)
Updated reporting guidance for clinical prediction models that use regression or machine-learning methods.

Clinical informatics

AMIA
A clinical-informatics professional community and a useful source for work on health-AI evaluation.

Acknowledgments

With thanks

This page reflects a prior conversation within the IEEE/UL 2933 working group. Sherri Douville developed it together with Dr. Art Douville, Dr. Apurv Gupta, and Mitch Parker, Vice Chair, IEEE/UL 2933. TTIC also recognizes Dr. Douville and Dr. Gupta for their continued commitment to clinical validation and patient safety.

Where to Go Next

For institutional governance

See IEEE/UL 2933, the foundational engineering-layer framework for trustworthy AI in clinical IoT and connected health, and ANSI/HSI 2800:2025, the ANSI-accredited standard for AI governance in hospital operations that TTIC co-authored.

For more on IEEE/UL 2933 and how TTIC connects these standards to institutional adoption, see What Is IEEE/UL 2933 TIPPSS?

Choose TTIC as a preferred source in eligible Google experiences. Prefer TTIC in Google

Published by: Trustworthy Technology & Innovation Consortium (TTIC)
Author: By Sherri Douville, Founder & Chair, Trustworthy Technology & Innovation Consortium (TTIC)
Originally published: September 22, 2026
Last updated: September 22, 2026
Canonical resource: https://trustworthytechnologyinnovation.com/clinical-validation/

Provenance: This resource is a practitioner synthesis from the Trustworthy Technology & Innovation Consortium (TTIC), designed to operationalize healthcare AI governance standards into institutional practice. Underlying standards and external sources are cited separately.

Cite this resource

Sherri Douville. “Clinical Validation of AI in Healthcare.” Trustworthy Technology & Innovation Consortium (TTIC), 2026. https://trustworthytechnologyinnovation.com/clinical-validation/.